In contrast, an increase in MUC2, MUC3A, MUC12, MUC16, and MUC17 mRNA expressions was strongly linked to the unfavourable OS in NSCLC (Figures 3(a)–3(g)). This evidence concerns the gene MUC16 and non-small cell lung carcinoma.